 84 (36,7%), C1 53 (22,1%), B2 49 (21,4%), D 17 (7,4%), B1 14 (6,1%) et A 12 (5,1% des cas
carcinomes. Mal cancers thyroïdiens différenciés ont représenté 28 cas (7,8% 
INTRODUCTION
Colorectal cancer is a common malignancy with annual incidence of over 945 000 new cases worldwide and mortality of 492 000. 1 The highest incidence rates of the disease are noted in North America and Western Europe with the lowest incidence rates reported from developing countries. 2 It is the fourth most common cancer diagnosed and the second most common cause of cancer deaths in the U.S. accounting for an estimated 145,290 new cancer cases and 56,290 deaths in the year 2005.
3 Similar rankings are reported in most western countries. 4 Recent data from North America have continued to show a decrease in incidence rates of colorectal carcinoma in whites since the mid-1980s, particularly for the distal colon and rectum following the advent of flexible sigmoidoscopy and polypectomy. In the late 1970s, incidence rates for metastatic disease among whites began to decline. 5, 6, 7 The decline in incidence rates among whites largely has been attributed to more widespread screening for colorectal carcinoma. However, similar trends by stage have not been observed in European and in North American blacks. 2 The incidence of cancer and chronic non-communicable diseases is increasing in developing countries owing to increased life expectancy and probably changes in risk factors that occur with economic development.
In Accra, Ghana, cancer of the colon and rectum is the third most common malignancy diagnosed 8 and the 10 th cause of cancer deaths. It represents the 8 th and the 9 th cause of cancer deaths in males and females respectively 9 at Korle-Bu Teaching Hospital. Accra is a cosmopolitan city, however a greater proportion of the population is made up of indigenous Africans who have not travelled out of the country. This analysis of colorectal carcinoma diagnosed at the main referral hospital where colorectal cancer surgery is performed gives an update of the disease in a purely black population.
SUBJECTS, MATERIALS, AND METHODS
Since the last report on colorectal cancer from this centre in 1994 10 tracking of new colorectal cancer cases seen at the centre was maintained. Records of cases seen at the endoscopy unit and the four general surgical wards where these patients were admitted and treated were evaluated prospectively. Each patient's presenting symptoms, physical signs and endoscopic findings were evaluated following which they were followed through their management in the hospital. The type of surgery they underwent as well as the chemotherapeutic and radiation treatments were studied. The immediate complications of these patients following surgery or chemoradiation were assessed as well as the causes of deaths after surgery. The final histopathology reports of specimens obtained either by biopsy or resection were obtained from the Pathology Department. This analysis involves 359 confirmed cases of colorectal cancers that were seen at the Korle-Bu Teaching Hospital between January 1997 and December 2007.
The data extracted for analysis included the patient's demography, presenting symptoms, treatment given and outcome, location of tumour, pathological stage of the tumour in the resected specimen, the histopathological type and grade of cancer.
RESULTS
From January 1997 to December 2007, 359 new cases of colon and rectal cancers were diagnosed and treated at the Korle-Bu Teaching Hospital. This gives an annual incidence rate of 32.6 cases. Males (192) and females (167) were affected in approximately equal proportions.
The sex, average annual incidence rate and age-specific incidence rates per 100,000 population for each decade are shown in Figure 1 and Table 1 . The crude incidence rates of colorectal cancers were 12.53 (males), 9.87 (females) and 11.18 (total population) per 100,000 population. There were 233 (64.9%) patients aged less than 60 years and 126 (35.1%) patients aged 60 years or more. Table 3 gives the histological types of colorectal cancers with adenocarcinoma in 321 (89.4%) patients being the most common.
The Astler Coller stages of the tumours in patients who had surgery are shown in Table 4 . Tumours were advanced at the time of presentation in many patients. One hundred and one patients had invasive well differentiated adenocarcinoma (Not Otherwise Stated, NOS) with 78 (48.5%) of these located in the rectum. Sixty-one patients with well differentiated tumours did not undergo surgery. Invasive moderately well differentiated and anaplastic carcinomas were present in 122 patients. Of these 64(52.5%) were located in the rectum. Forty-eight of these patients did not have surgery.
One hundred and sixty-eight rectal carcinomas were diagnosed, with a female preponderance of 93, mean age of 52.87 years to 75 males, mean age of 55.26 years. The pathological stages of the 50 rectal carcinomas that were resected were A 2, B 1 6, B 2 9, C 1 10, C 2 23 D 0. The remaining 118 patients did not undergo surgery.
Data on long term survivals are not available as the majority of patients were lost to follow-up. Twenty-nine patients (12.6%) developed a total of 36 complications while 14 patients (6.1%) died in the early post-operative period. Significant morbidities that occurred included wound infection nine, deep vein thrombosis eight, anaemia five, pereneal wound break down five, anastomotic leak two, intra-abdominal abscess four, chest infection two, anastomotic break down one. The causes of death included septicaemia six, pulmonary embolism four, anaemia two, subdural haemorrhage and renal failure one each. 
DISCUSSION
Colon and rectal cancers are diseases of advancing age with the incidence rising sharply after the sixth decade. 4, 11 In 1966 Badoe 12 presented the first report of colon and rectal cancers in Accra, Ghana. The incidence then was approximately 4.1 new cases per year in a population of about 400,000. 13 . There has been an increase in the incidence of colorectal cancer in Accra over the past four decades as shown in Table 5 . [14] [15] [16] [17] [18] In this study, the number of new cases seen annually was 32.8 in a population of about 3,000,000 18 . The crude incidence rate was 11.18 per 100,000 population in both sexes combined. This incidence rate is very much lower than those reported from North America and Europe. [19] [20] [21] [22] [23] The demographic profile of Accra reveals that currently the proportion of the population aged 60 years and over has risen from 2.6 percent in 1984 to 3.9 percent in 2000. [16] [17] [18] This small population however accounted for 35.1% of the people afflicted and this supports the notion that colorectal cancer is a disease of old age and that as the population ages in Ghana and other developing countries the incidence of this disease will continue to rise.
Diet is currently the most important exogenous factor identified in the causation of colorectal cancer. Intake of refined diet that increases the pH of the colon and increases transit time has been postulated to be important in the development of colorectal cancers. 24, 25 The increasing urbanization of Accra does not appear to be accompanied by significant changes in dietary habits towards a Western diet. 26 It has been shown that the difference between the dietary fibre intake of high income earners (43.5g/day) in Accra and low income earners (39.0g per day) was not statistically significant and the average daily fibre intake of 39.4g/day is much higher than what obtains in the western world. 27 Another study also found that the intake of insoluble fibre is similar for both rural and urban dwellers. It showed further that the bowel function of urban dwellers is similar to that of their rural counterparts whose diets are largely plant-based; high in fibre and low in fat. 28 It could therefore be concluded that people who live in Accra have tended to stick to foods that they have been traditionally accustomed to. This could partly be responsible for the comparatively low incidence of colorectal cancer in Accra. While the low incidence of the disease may be explicable by the intake of "protective diet" the observed progressive rise in the incidence of colorectal cancer over the past years cannot be similarly accounted for. Further local studies into the molecular genetics of these tumours are needed to help explain the rising incidence of the disease in Accra.
Survival of colorectal cancer patients depends mostly on their disease stage at the time of diagnosis. 29 Patients with colon and rectal cancer still report late to hospital even in the developed world. 30 In this study 203 out of 231 (87.9%) patients who had surgery presented with late disease (Astler Coller stages B 2 or worse). A number of factors accounted for the late presentation with colorectal cancer. The significance of warning symptoms may not be obvious to many patients 31 who may not relate them to serious disease and so be ignored. Rectal bleeding is an important symptom in colorectal cancer. It was the most frequent and longest standing symptom in 51.1% patients (mean duration of 18 months). Single symptoms (frequent in early disease) are associated with long delay in diagnosis compared with multiple symptoms (indicating advanced disease) which are associated with shorter delay. 32, 33 In fact, in this study change in bowel habit in 1.7% of patients (mean duration of six months), abdominal masses in 21.1% patients (mean duration five months), and abdominal pain in 1.4% patients (mean duration seven months) were symptoms obtained from the patients after repeated questioning and so were infrequently the index symptoms prompting hospital visit. For most of those who recognized these symptoms they were noticed in combination within six months of presentation. Presumably, these patients could have noticed earlier warning symptoms but did not pursue them for fear of a cancer diagnosis. 23 Majority of the patients with late disease in this study denied ever noticing any early single warning symptom. Intestinal obstruction (17.3%) and perforation (2.5%) presented as emergencies. Colorectal endoscopic screening has greatly improved the detection rates of early disease (Stages I and II disease) in the West, more so in whites than in blacks. 5 The stage of colorectal cancer at time of diagnosis reported in the US 7 .4%. The low number of Stage I tumours seen in this study is the result of absence of population screening programmes in this country. Also the relatively low number of Stage IV tumours was because of the low number of rectal tumours that were resected since many of the unresected ones were advanced tumours that were staged clinically. Performing colorectal endoscopy routinely on older patients with haematochezia might be an appropriate option by which many early tumours could be diagnosed. Indeed, flexible sigmoidoscopy should be the minimum endoscopic investigation employed in patients with haematochezia in our environment since as many as 67.1% (241 out of 359) of the tumours reported in this study were located in the left colon and the rectum. This assertion has been corroborated by a recent study that evaluated the place of either whole colonic imaging or flexible sigmoidoscopy in patients with colorectal symptoms. 34 Of the 321 patients with adenocarcinoma all except four had invasive tumour. The patients with carcinoma-insitu presented with rectal bleeding and had endoscopy which identified their tumours that were subsequently resected after histological confirmation of the diagnosis.
Rectal cancers had the lowest resection rate of 29.8% in this study. Patients refused rectal surgery so as to avoid a permanent colostomy. Financial constraints, unresectability of advanced tumour and increased incidence of morbidity after neo-chemoradiation were the other negating factors. Cardiovascular disease was a frequent morbid complication of irradiation and prevented or delayed surgical resection in these patients. Postoperative mortality was 6.1% but data on long term survival are not available as the majority of patients failed to report for follow up.
Conclusion
Colorectal cancer is a complex genetic disease with everonmental factors playing some role in their causation. These cancers are becoming frequently recognized solid tumours in clinical practice in Accra. Their age specific incidence rates rise shapely from age 40 years. The annual new cases of carcinoma of the large bowel has progressively increased over the past four decades in tandem with an aging population of the city. Invasive adenocarcinoma was the commonest cancer. Rectal bleeding was a frequent presenting symptom however this symptom was usually overlooked by the patients who then presented late with advanced tumours. Surgery as a mandatory aspect of the treatment was not applied to a majority of the patients with rectal cancer due to in-operatiblity of the tumours at presentation and refusal of the patients to have a colostomy Colorectal cancers are no longer uncommon among the indigenous people of Accra. Afflicting people who are younger than found in the developed world these cancers are aggressive and are mostly incurable at presentation. Further studies to eludate the molecular genetics of these cancers is recommened.
